| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/12/2001 | WO2001049875A1 Predictive diagnostic for alzheimer"s disease |
| 07/12/2001 | WO2001049874A1 Methods and systems for monitoring intracellular binding reactions |
| 07/12/2001 | WO2001049873A1 Method for preparing a model system for cellular insulin resistance and device for use with the model system |
| 07/12/2001 | WO2001049851A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | WO2001049846A1 32164 protein, a novel seven transmembrane protein |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049823A2 Assays for detection of bacillus anthracis |
| 07/12/2001 | WO2001049790A2 Mobility-modifying cyanine dyes |
| 07/12/2001 | WO2001049745A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | WO2001049729A2 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | WO2001049719A2 Activators of caspases |
| 07/12/2001 | WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 07/12/2001 | WO2001049708A2 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 07/12/2001 | WO2001049687A2 Cyclohexene nucleic acids |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001011373A3 Difference detection methods using matched multiple dyes |
| 07/12/2001 | WO2001011334A3 Method of diagnosing irritable bowel syndrome and other diseases by detecting anti-saccharomyces cerevisiae antibody |
| 07/12/2001 | WO2001007087A8 Enzyme catalyzed anti-infective therapeutic agents |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2001002853A3 DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY |
| 07/12/2001 | WO2001002370A9 Nickel-based reagents for detecting dna and dna-protein contacts |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000073786A3 Device for measuring the frictional properties of textile fibers |
| 07/12/2001 | WO2000073420A3 Creation of human tumorigenic cells and uses therefor |
| 07/12/2001 | WO2000069391A3 CRYSTAL STRUCTURE OF RIBOSOMAL PROTEIN L11/GTPASE ACTIVATING REGION rRNA AND USES THEREOF |
| 07/12/2001 | WO2000066786A3 Polynucleotide probes for detection and quantitation of actinomycetes |
| 07/12/2001 | WO2000056144A9 Human sperm surface antigen |
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO2000033066A3 Apparatus and method for wireless gas monitoring |
| 07/12/2001 | WO2000028460A3 Diagnostic device for health monitoring and network-based health assessment system and medical record maintenance system |
| 07/12/2001 | WO2000004041A3 Methods and molecules relating to cd39-like polypeptides |
| 07/12/2001 | WO1999064559A3 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007854 Reacting cultured brain slices with free radical generatorin presence of lysosomal enzymes |
| 07/12/2001 | US20010007775 Colloidal particles at interface between electrode and electrolytes |
| 07/12/2001 | US20010007774 Immobilized antibody |
| 07/12/2001 | US20010007773 Method for determining analyte level |
| 07/12/2001 | US20010007770 Sucking, discharging a liquid |
| 07/12/2001 | US20010007769 Computer diagnosis of cardiovascular disorders |
| 07/12/2001 | US20010007753 Detection of mutant; gene expression; determination endocytosis; calibration |
| 07/12/2001 | US20010007748 Medical diagnosis |
| 07/12/2001 | US20010007746 Immobilization |
| 07/12/2001 | US20010007745 Genetic engineering |
| 07/12/2001 | US20010007740 Compound library |
| 07/12/2001 | US20010007713 Precipitation from aqueous solution |
| 07/12/2001 | US20010007674 Stimulate hair growth |
| 07/12/2001 | US20010007661 Or mutein or salt thereof, for treating or preventing Sjogren's syndrome |
| 07/12/2001 | US20010007643 Receptacles for containing one or more substances; transfer device capable of taking contact-limiting elements from holding structure into contact with receptacle substances |
| 07/12/2001 | US20010007357 Semiconductor device and a manufacturing method thereof |
| 07/12/2001 | US20010007315 Gel barrier in interior surface of tube |
| 07/12/2001 | DE3943817C2 New luminescent dyes |
| 07/12/2001 | DE19963619A1 Determining exposure to organochlorine pollutants, by analysis of meconium to provide a summation parameter representative of actual fetal exposure during pregnancy |
| 07/12/2001 | DE19962828A1 Screeningsverfahren für Chemotherapeutika Screening method for chemotherapeutic agents |
| 07/12/2001 | DE19962577A1 Chromatographiematerial und Verfahren unter Verwendung desselben The same chromatographic and methods using |
| 07/12/2001 | DE19962263A1 Verfahren zur Feststellung neurologisch relevanter Eigenschaften eines Materials Procedure for determining neurologically relevant properties of a material |
| 07/12/2001 | DE19962154A1 Krankhaft veränderte Herzmuskelzelle, ihre Herstellung und Verwendung Diseased heart muscle cell, their preparation and use |
| 07/12/2001 | DE19830727C2 Vorrichtung, Sensorelement und Verfahren zum Nachweis physikalischer oder chemischer Wechselwirkungen Apparatus, sensor element and method for the detection of physical or chemical interactions |
| 07/12/2001 | DE10004065A1 Assessment of level of contamination in soil and water involves using matrix of risk factors together with sensitivity and vulnerability aspects to determine corrective measures needed for effective decontamination |
| 07/12/2001 | DE10000148A1 Device for on-board measurement of usage-characteristics of motor oil, has capacitor arrangement containing oil of varying dielectric constant, with adapter component forming electrodes of capacitor |
| 07/12/2001 | DE10000046A1 Device to determine strength and taste intensity of tea, has display element connected to teabag or infuser, which includes sensor element to detect heat or moisture |
| 07/12/2001 | CA2402131A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | CA2396696A1 Assays for detection of bacillus anthracis |
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396301A1 Method for concurrent amplification and real time detection of polymorphic nucleic acid sequences |
| 07/12/2001 | CA2396127A1 Gene expression in biological conditions |
| 07/12/2001 | CA2396067A1 Mobility-modifying cyanine dyes |
| 07/12/2001 | CA2395999A1 Screening using biological target molecules with metal-ion binding sites |
| 07/12/2001 | CA2395625A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | CA2394730A1 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | CA2329318A1 Transgenic animal model of basal cell carcinoma |
| 07/12/2001 | CA2328634A1 Assay method |
| 07/11/2001 | EP1114998A2 Method for determining the success rate of treatment of multiple sclerosis |
| 07/11/2001 | EP1114997A2 Blood testing tool |
| 07/11/2001 | EP1114996A2 Cell and method for electrochemical analysis of a sample |
| 07/11/2001 | EP1114995A2 Cell and method for electrochemical analysis of a sample |
| 07/11/2001 | EP1114992A2 Device and method for hydrogen collection and detection |
| 07/11/2001 | EP1114870A1 Methods for fractional quantification of cholesterol in lipoproteins and quantification reagents |
| 07/11/2001 | EP1114864A2 Mammalian cell surface antigens, related reagents |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114679A1 Method for producing soil, soil-treating unit, method for treating and unit for treating |
| 07/11/2001 | EP1114393A1 Spectral bio-imaging data for cell classification using internal reference |
| 07/11/2001 | EP1114323A1 Cobalamin assay |
| 07/11/2001 | EP1114322A1 Tandem immuno-assay for cancer |
| 07/11/2001 | EP1114321A2 Salmonella antigen formulation and kit for detecting salmonella antibodies |
| 07/11/2001 | EP1114320A2 A system for cell-based screening |
| 07/11/2001 | EP1114319A1 Composite devices incorporating biological material and methods |
| 07/11/2001 | EP1114318A1 Quality control system for monitoring and control of contaminants in recycled plastics |
| 07/11/2001 | EP1114317A2 Signal detection techniques for the detection of analytes |
| 07/11/2001 | EP1114314A1 Device comprising a plurality of analysis sites on a support |
| 07/11/2001 | EP1114306A1 Volatile biomarkers for analysis of hepatic disorders |
| 07/11/2001 | EP1114299A1 Microwave resonator for continuous evaluation of fibrous materials |
| 07/11/2001 | EP1114187A1 Geometrical and hierarchical classification based on gene expression |
| 07/11/2001 | EP1114183A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/11/2001 | EP1114178A1 Nucleic acid sequencing with solid phase capturable terminators |
| 07/11/2001 | EP1114177A1 Assay member and method for its manufacture |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |